BioCentury
ARTICLE | Clinical News

Alexion Pharmaceuticals preclinical data

April 3, 1995 7:00 AM UTC

The New Haven, Conn., company presented preclinical findings showing that its packaging cell lines produce retroviral particles deficient in alphaGal, the carbohydrate epitope that signals complement activation when bound to antibodies. ...